Cargando…

PB2439: EARLIER ENGRAFTMENT WITHOUT INCREASE OF GVHD IN HIGHER DOSE OF CD34+ CELLS IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales:	Tan, Tran-Der, Chiou, Lun-Wei, Chen, Rong-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429439/ http://dx.doi.org/10.1097/01.HS9.0000976460.67993.b8

Ejemplares similares

PB2449: EFFECT OF MOBILIZATION METHODS ON CD34+ AND TOTAL NUCLEATED CELL COUNT AND THEIR RELATION WITH ENGRAFTMENT IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Beyler, Ozlem, et al.
Publicado: (2023)

PB2338: QUALITY OF LIFE AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: IMPACT OF CHRONIC GVHD
por: Belloumi, D., et al.
Publicado: (2022)

PB2418: CLINICAL FEATURES AND PROGNOSIS OF ADENOVIRUS INFECTION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, Wei, et al.
Publicado: (2023)

PB2462: IMPACT OF ENGRAFTMENT SYNDROME ON THE DEVELOPMENT OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC/HAPLOIDENTICAL PERIPHERAL BLOOD HSCT IN A SINGLE CENTER IN MEXICO.
por: Daniel Garza Escobar, Juan, et al.
Publicado: (2023)

PB2189: HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH SEVERE CONGENITAL NEUTROPENIA:A CASE REPORT OF 13 YEARS OLD PATIENT
por: Wang, J., et al.
Publicado: (2022)

PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION
por: Mancusi, Antonella, et al.
Publicado: (2023)

PB2445: THE ROLE OF MEDITERRANEAN DIET IN CHRONIC GVHD: A PILOT STUDY
por: Brambilla, Giulia, et al.
Publicado: (2023)

PB2441: CD34+ CELL DOSE EFFECTS ON CLINICAL OUTCOMES OF ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)
por: Zhou, Shengnan, et al.
Publicado: (2023)

PB2434: DONOR CELL INDUCING IMMUNE-TOLERANCE IMPROVED ENGRAFTMENT IN TΑΒ+ CELL DEPLETED HSCT IN PATIENTS WITH THALASSEMIA MAJOR
por: Liao, Jianyun, et al.
Publicado: (2023)

PB2190: HLA-HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE AFTER REDUCED-INTENSITY CONDITIONING
por: Kim, J., et al.
Publicado: (2022)

PB2186: INTENSITY OF THE CONDITIONING REGIMEN AND TIMING OF AUTOGRAFT ENGRAFTMENT IN PATIENTS WITH MULTIPLE MYELOMA
por: Kostroma, I., et al.
Publicado: (2022)

PB2187: VIABILITY AND PROLIFERATIVE POTENTIAL OF AUTOGRAFT HEMATOPOIETIC STEM CELLS
por: Balashova, V., et al.
Publicado: (2022)

PB2181: DOES SARCOPENIA INFLUENCE THE SUCCESS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION?
por: Erdogan Yucel, E., et al.
Publicado: (2022)

PB2203: AGEING OF LONG-TERM ALLOGENEIC HEMATOPOIETIC CELLS RECIPIENTS COMPARED TO THEIR DONORS
por: Czarnogórski, M., et al.
Publicado: (2022)

PB2199: A REAL WORLD STUDY OF PEG-RHG-CSF ON HEMATOPOIETIC RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Xu, J., et al.
Publicado: (2022)

PB2194: ISCHEMIC STROKE IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Pérez Raya, M., et al.
Publicado: (2022)

PB2581: BACILLUS BACTEREMIA IS DETECTED EARLIER THAN OTHER GRAM-POSITIVE RODS IN BLOOD CULTURES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.
por: Mori, Yuto, et al.
Publicado: (2023)

PB2452: PREVALENCE AND SEVERITY OF COVID-19 IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS IN CHINA
por: Gao, Hongye, et al.
Publicado: (2023)

PB2474: CONSTRUCTION OF NURSING SCHEME FOR PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION TO PREPARE FOR DISCHARGE
por: Wang, LI, et al.
Publicado: (2023)

PB2448: RESTORATION OF HEMOGRAM PARAMETERS IN PATIENTS WITH HEMOBLASTOSIS AFTER TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS
por: Natalia, Isaeva, et al.
Publicado: (2023)

PB2573: MICRORNA CLUSTERS FACILITATE THE PREDICTION OF INFECTIOUS FEVER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Liu, LI, et al.
Publicado: (2023)

PB2007: FACTORS ASSOCIATED WITH EARLY RELAPSE IN MYELOMA PATIENTS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Karatas, A., et al.
Publicado: (2022)

PB2468: A RETROSPECTIVE STUDY OF ELTROMBOPAG IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: MA, Liangming, et al.
Publicado: (2023)

PB2694: EFFECT OF NARRATIVE NURSING ON ANXIETY, DEPRESSION AND STIGMA IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tang, Jie, et al.
Publicado: (2023)

PB2406: EFFECT OF PINK NOISE ON IMPROVING SLEEP QUALITY OF PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Wu, Fangfang, et al.
Publicado: (2023)

PB2174: ON THE ROBUSTNESS OF THE BUCCAL EPITHELIUM FOR ASSESSING RECIPIENT DNA PROFILE IN PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Risinskaya, N., et al.
Publicado: (2022)

PB2198: EFFECTS OF NOVEL CORONAVIRUS VACCINATION ON THE COLLECTION OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS FROM HEALTHY DONORS
por: Wang, Z., et al.
Publicado: (2022)

PB2412: OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS–SINGLE CENTRE EXPERIENCE FROM PAKISTAN
por: Hussain, Mussawair, et al.
Publicado: (2023)

PB2464: STRATIFICATION AND IMMUNOLOGIC ANALYSIS OF PATIENTS WITH SARS-COV-2 INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Chen, Man, et al.
Publicado: (2023)

PB2417: PRESENCE´S IMPACT OF NON-SPECIFIC ANTI-HLA ANTIBODIES ON THE DEVELOPMENT OF PRIMARY GRAFT FAILURE IN PATIENTS UNDERGOING PERIPHERAL BLOOD HAPLOIDENTICAL HSCT, EXPERIENCE AT A CENTER IN MEXICO.
por: Daniel Garza Escobar, Juan, et al.
Publicado: (2023)

PB2355: EFFECTS OF CHRONIC DISEASE LOCUS INTERVENTION MODEL ON QUALITY OF LIFE AND STRESS IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, A., et al.
Publicado: (2022)

PB2458: CONSTRUCTION AND APPLICATION OF MULTI-DISCIPLINARY NUTRITION MANAGEMENT PLAN FOR MALNOURISHED PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Sun, Hengrui, et al.
Publicado: (2023)

PB2661: UPPER LIMB VENOUS THROMBOSIS ASSOCIATED WITH PICC AND ITS INFLUENCING FACTORS IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Tang, Jie, et al.
Publicado: (2023)

PB2423: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH PRIOR INFECTION CAUSED BY THE SARS-COV-2 (COVID-19)
por: Siniaev, Aleksandr, et al.
Publicado: (2023)

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
por: Gavriilaki, E., et al.
Publicado: (2022)

PB2695: ANALYSIS OF THE CURRENT SITUATION AND FACTORS INFLUENCING PSYCHOLOGICAL DISTRESS OF HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS IN THE LAMINAR FLOW WARD
por: Wen, Jing, et al.
Publicado: (2023)

PB2408: PREVALENCE OF METABOLIC SYNDROME IN LONG TERM HEMATOPOIETIC STEM CELL TRANSPLANTATION SURVIVORS: COMPARISON WITH A MATCHED REFERENCE COHORT.
por: van Yperen, Nicole, et al.
Publicado: (2023)

PB2451: EVALUATION OF PLATELET PARAMETERS IN PATIENTS WITH SECONDARY FAILURE OF PLATELET RECOVERY AND CYTOMEGALOVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Cao, Yigeng, et al.
Publicado: (2023)

PB2456: SURVIVAL OF MULTIPLE MYELOMA PATIENTS YOUNGER AND OLDER THAN 60 YEARS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Kostroma, Ivan, et al.
Publicado: (2023)

PB2090: TREATMENT OUTCOME OF ORBITAL MARGINAL ZONE B CELL LYMPHOMA -- TEN YEARS FOLLOW UP IN A SINGLE INSTITUTION
por: Tan, T.-D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s2l2tlnblgms8763d3qt1ip6gq